MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Hypercholesterolemia | D006937 | 91 associated lipids |
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
tritriacontanoic acid is a lipid of Fatty Acyls (FA) class. Tritriacontanoic acid is associated with abnormalities such as hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent and Parkinson Disease. The involved functions are known as Fermentation, Process, Longterm Effects, Pressure- physical agent and Lipid Metabolism. Tritriacontanoic acid often locates in Blood, Tissue fiber and A Fibers. The associated genes with tritriacontanoic acid are STN gene. The related lipids are Total cholesterol and blood lipid.
To understand associated biological information of tritriacontanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
tritriacontanoic acid is suspected in hypercholesterolemia, Metabolic syndrome, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Insulin-Dependent, Parkinson Disease and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with tritriacontanoic acid
MeSH term | MeSH ID | Detail |
---|---|---|
Body Weight | D001835 | 333 associated lipids |
Hypercholesterolemia | D006937 | 91 associated lipids |
Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Noble JA and Grannis FW | Acute esophageal obstruction by a psyllium-based bulk laxative. | 1984 | Chest | pmid:6488929 |
RodrÃguez-Cabezas ME et al. | Intestinal anti-inflammatory activity of dietary fiber (Plantago ovata seeds) in HLA-B27 transgenic rats. | 2003 | Clin Nutr | pmid:14512034 |
Miettinen TA and Tarpila S | Serum lipids and cholesterol metabolism during guar gum, plantago ovata and high fibre treatments. | 1989 | Clin. Chim. Acta | pmid:2553302 |
McConnochie K et al. | Ispaghula sensitization in workers manufacturing a bulk laxative. | 1990 | Clin. Exp. Allergy | pmid:2357618 |
Cicero AF et al. | Different effect of psyllium and guar dietary supplementation on blood pressure control in hypertensive overweight patients: a six-month, randomized clinical trial. | 2007 | Clin. Exp. Hypertens. | pmid:17729055 |
Song YJ et al. | Soluble dietary fibre improves insulin sensitivity by increasing muscle GLUT-4 content in stroke-prone spontaneously hypertensive rats. | Clin. Exp. Pharmacol. Physiol. | pmid:10696527 | |
Shulman RJ et al. | Psyllium Fiber Reduces Abdominal Pain in Children With Irritable Bowel Syndrome in a Randomized, Double-Blind Trial. | 2017 | Clin. Gastroenterol. Hepatol. | pmid:27080737 |
Gillespie BF and Rathbun FJ | Adverse effects of psyllium. | 1992 | CMAJ | pmid:1728348 |
Coggrave M et al. | Management of faecal incontinence and constipation in adults with central neurological diseases. | 2006 | Cochrane Database Syst Rev | pmid:16625555 |
Wiesel PH et al. | Management of faecal incontinence and constipation in adults with central neurological diseases. | 2001 | Cochrane Database Syst Rev | pmid:11687140 |